Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document says there are five types of hair loss conditions and different causes, including drugs.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Wnt signaling is important for the change from the resting phase to the growth phase in human hair cycles.

The dietary supplement helped increase hair growth in women with hair loss.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

COVID-19 may cause hair loss due to infection stress or treatments.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

BMP6 and Wnt10b control whether hair follicles are resting or growing.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

UV rays can cause a type of hair loss known as telogen alopecia.

Personality traits and anxiety affect hair loss patients' quality of life.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Taking zinc supplements can help improve or cure hair loss caused by zinc deficiency.